National Institutes of Health (NIH)
Bethesda
MD
United States
203 articles with National Institutes of Health (NIH)
-
Scientists call for more investigation into the origin of the virus, particularly in China, but China now wants to include the U.S. in the probe.
-
Besides providing a sense of hope for children with this devastating disease, this research could offer another clue toward unlocking the mystery behind other forms of ALS.
-
Molecular Partners Announces First Patient Dosed in COVID-19 NIH-Sponsored ACTIV-3 Trial Evaluating Antiviral Candidate Ensovibep
6/13/2021
Molecular Partners AG announced that the first patient has been dosed in a new Phase 3 sub-study evaluating ensovibep, as part of the National Institutes of Health's Accelerating COVID-19 Therapeutic Interventions and Vaccines public-private partnership designed to speed development of treatments and vaccine candidates for COVID-19.
-
NYU Langone Health to Co-Lead NIH-funded Effort to Understand Long-term Effects of SARS-CoV-2 Infection
6/10/2021
NYU Langone Health has been selected as the Clinical Science Core for the National Institutes of Health's PASC Initiative. In this role, the CSC could potentially receive up to $52 million over the full funding period to lead and integrate the research activities of clinical sites around the country studying the long-term effects of SARS-CoV-2 infection.
-
VisionQuest Receives a $2M NIH Grant to Commercialize an Artificial Intelligence System Used to Improve and Save the Lives of African Children Affected with Malaria
6/9/2021
VisionQuest Biomedical Inc. announces that it has been awarded a $2M grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to commercialize ASPIRE, a device that uses artificial intelligence to improve the diagnosis of cerebral malaria.
-
Pascal Biosciences Awarded NIH Grant For Leukemia Program
6/8/2021
Pascal Biosciences Inc., has been awarded a grant of US$343,750 from the National Cancer Institute of the US National Institutes of Health.
-
Clinical Catch-Up: June 1-6
6/7/2021
With the 2021 American Society of Clinical Oncology meeting held late last week, there is plenty of clinical trial news. -
A flurry of COVID-19 research news came out today. Here’s a look.
-
First National Institute of Health (NIH) Grant Awarded to Rush Sports Medicine Surgeon
5/26/2021
For the first time in Midwest Orthopaedics at Rush history, one of its sports medicine physicians has been awarded a National Institute of Health grant as a Principal Investigator.
-
Enspectra Health Receives $4.0 Million NIH Grant to Advance a New Field of Virtual Biopsies
5/26/2021
Enspectra Health, a digital health company dedicated to pioneering the field of virtual biopsies, announced that it has received a Phase IIB award of $4.0 million under the National Institutes of Health's Small Business Innovation Research Program for the continued development of its novel imaging technology to aid in the evaluation of nonmelanoma skin cancers.
-
FluGen Initiates NIH-Funded Trial of M2SR Flu Vaccine; First Study in Adults Up to Age 85
5/25/2021
Study will measure immune responses to matched and drifted virus strains in older adults, a population that is most vulnerable to mortality from flu
-
Social & Health Research Center and Quest Diagnostics Team Up to Address Childhood Hunger and Obesity Exacerbated by COVID-19 in Underserved Communities
5/24/2021
Childhood obesity has disproportionately affected Hispanic and Black communities as a result of negative social determinants of health for years.
-
Baebies Awarded $2.7 Million NIH Grant for Rapid, Near-patient Heparin Monitoring Requiring Low Sample Volume
5/19/2021
Baebies, a growth-stage company developing innovative products to enable early disease detection and multifunctional diagnostics for syndromic testing, was recently awarded $2.7 million in a Phase IIB SBIR grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.
-
Comments on social media provide a glimpse at the deep divide in trust of public health agencies, and now a new survey demonstrates the breadth of that distrust.
-
Feinstein Institutes Receives $3.7M NIH Support for Bioelectronic Medicine Research
5/6/2021
Dr. Kevin J. Tracey, bioelectronic medicine pioneer and president and CEO of the Feinstein Institutes, will oversee the multi-year study
-
Xtrava Health Receives NIH Funding for Their SPERA™ COVID-19 Ag Test
4/28/2021
Xtrava Health, a health technology company, announced it has been awarded a $6.2 million contract by the National Institutes of Health under the Rapid Acceleration of Diagnostics initiative to expedite the launch of its SPERA™ COVID-19 antigen test.
-
Ceres Nanosciences Receives $8.2M NIH Award to Improve Wastewater-Based COVID-19 Surveillance
4/21/2021
Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve diagnostic testing, is announcing today that it has been awarded a contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx SM ) Initiative for $8.2 million
-
A $25 million grant from the National Institutes of Health Helping to End Addiction Long-term Initiative (HEAL) is funding new research to develop a vaccine that may help patients overcome their addiction to opioids, a class of highly addictive pain medications.
-
COVID-19 News: Researchers Discover a New Variant, Antiviral Shows Promise in Hamsters and More
4/20/2021
Please check out the biopharma industry's COVID-19 stories that are trending for April 20, 2021. -
Clinical Catch-Up: April 5-9
4/12/2021
It was a relatively quiet week for clinical trial announcements, but there were a few standouts. Read on for more.